MDxHealth SA ADR (MDXH) has had the highest return this decade by a US stock in the Biotechnology Industry, returning 420,809.1%.

ASSET	DECADE	% RETURN
MDxHealth SA ADR (MDXH)	2020s	420,809.09%
Azitra (AZTR)	2020s	12,400%
Regencell Bioscience (RGC)	2020s	4,681.51%
NewAmsterdam Pharma Company NV Warrant (NAMSW)	2020s	1,719%
Summit Therapeutics (SMMT)	2020s	1,209.38%
Celldex Therapeutics (CLDX)	2020s	1,066.96%
COSCIENS Biopharma (CSCI)	2020s	957%
Protagonist Therapeutics (PTGX)	2020s	850.92%
Indivior PLC Ordinary Shares (INDV)	2020s	748.23%
Abivax SA American Depositary Shares (ABVX)	2020s	614.14%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	2020s	564.26%
MoonLake Immunotherapeutics (MLTX)	2020s	510.14%
Insmed (INSM)	2020s	473.83%
Belite Bio Inc ADR (BLTE)	2020s	459.84%
Capricor Therapeutics (CAPR)	2020s	445.38%
Catalyst Pharmaceuticals (CPRX)	2020s	413.68%
United Therapeutics (UTHR)	2020s	389.71%
Merus (MRUS)	2020s	388.58%
Natera (NTRA)	2020s	381.31%
Cogent Biosciences (COGT)	2020s	378.38%
Cytokinetics (CYTK)	2020s	373.68%
Madrigal Pharmaceuticals (MDGL)	2020s	362.93%
Nuvalent (NUVL)	2020s	349.67%
argenx NV ADR (ARGX)	2020s	343.93%
Celcuity LLC (CELC)	2020s	342.31%